Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

|Videos|February 3, 2022

Supporting MRD Availability

Our experts tell us how we can support the availability of MRD for more patients.

Episodes in this series

EP. 1 Explaining Molecular Residual Disease

EP. 1 Explaining Molecular Residual Disease

EP. 2 The Evolution of Circulating Tumor DNA in Oncology

EP. 2 The Evolution of Circulating Tumor DNA in Oncology

EP. 3 MRD Assessments

EP. 3 MRD Assessments

EP. 4 MRD Results and Guiding Treatment Decisions

EP. 4 MRD Results and Guiding Treatment Decisions

EP. 5 MRD and Value-Based Care Models

EP. 5 MRD and Value-Based Care Models

EP. 6 Supporting MRD Availability

EP. 6 Supporting MRD Availability

EP. 7 INSPIRE and IMvigor011 Trials

EP. 7 INSPIRE and IMvigor011 Trials

EP. 8 Potential Changes for MRD in the Future

EP. 8 Potential Changes for MRD in the Future

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Woman with cancer in hospital bed speaking with her male doctor about treatment | Image Credit: Rido - stock.adobe.com

CRC Treatment Delays Linked to Higher Metastasis Risk, Supporting Pathway-Specific Benchmarks

ByBrooke McCormick

July 20th 2026

Globe and stethoscope | Image Credit: Planetz - stock.adobe.com

Early-Onset CKD Mortality Declines Globally as Incidence Continues to Rise

ByBrooke McCormick

July 20th 2026

The Road Ahead: Personalized Therapy, Combination Approaches, and Key Takeaways in Extrapulmonary Neuroendocrine Carcinoma

ByRyan Haumschild, PharmD, MBA,William K. Oh, MD,Aman Chauhan, MD,Namrata Vijayvergia, MD,Sandy Kotiah, MD

July 20th 2026

Doctor holding red and yellow ribbon | Image Credit: Ekaterina - stock.adobe.com

Hepatitis Prevention Programs Improve Liver Outcomes, but Gaps in Screening, Care Remain

ByBrooke McCormick

July 19th 2026

AI | Image Credit: kras99 - stock.adobe.com

AI Phenotyping Links Cardiovascular, Kidney Disease to Rapid MASH Progression, Higher Costs

ByBrooke McCormick

July 18th 2026

Trending on AJMC

FDA Approves Enlicitide, First Oral PCSK9 for High Cholesterol

Cardiology Prices Vary Widely by Insurer and State

Prior Cancer History Predicts Second Cancers in Polycythemia Vera, Essential Thrombocythemia

Medicaid MFN Pricing Could Save $8.6 Billion

Hepatitis Prevention Programs Improve Liver Outcomes, but Gaps in Screening, Care Remain